Nostrum Laboratories Inc. is recalling 4,722 bottles of Theophylline (Anhydrous) Extended-Release Tablets, 400 mg, which is a prescription medication used to treat asthma and other lung conditions. The recall was initiated because the product was incorrectly labeled with the wrong lot number and expiration date due to manufacturing errors. Consumers who rely on the expiration date for medication potency and safety may be using product that is not accurately tracked or could be older than indicated.
Incorrect labeling of expiration dates and lot numbers can lead to patients using medication beyond its intended shelf life, potentially resulting in reduced effectiveness or difficulty in tracking specific bottles if other safety issues arise.
Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.